No Cardiovascular Benefit Found for Rimonabant

More IMHO malpractice re: diet drugs.

The early promise of an anti-obesity drug may never be fulfilled following the discontinuation of a randomized trial for safety reasons and a subsequent data analysis showing no evidence of efficacy for the study's primary endpoint of reduced cardiovascular risk.

Give yourself a chance to shed the weight naturally, effectively and properly.